NJ HealthSource
FDA Approves First Drug for Sinusitis With Nasal Polyps
In what specialists say could be a turning point in care, the U.S. Food and Drug Administration on Wednesday approved the first drug to treat chronic sinusitis that involves the growth of polyps within the sinuses. Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and
